drug
alprostadil
Marketedupdated 3mo agoby Auxilium Pharmaceuticals LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 12 investigational indications.
all catalysts(20)
approval · 20
Oct 16, 1981
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Nov 29, 1982
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Apr 14, 1986
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Jul 10, 1987
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Oct 28, 1987
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Mar 31, 1988
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Mar 28, 1990
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Feb 11, 1992
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Jan 26, 1993
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Jun 26, 1993
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
May 4, 1994
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Jun 15, 1994
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Jan 10, 1995
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Apr 3, 2000
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Aug 13, 2001
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
May 1, 2002
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Dec 17, 2002
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Jun 9, 2014
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Jul 18, 2019
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Dec 22, 2025
approval
$PFE26.79-0.06%
PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approval
alprostadil
→
Trials studying alprostadil
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that